CBMG
Cellular Biomedicine Group, Inc.
CBMG
CBMG
Delisted
CBMG was delisted on the 19th of February, 2021.
34 hedge funds and large institutions have $27.6M invested in Cellular Biomedicine Group, Inc. in 2018 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 9 increasing their positions, 4 reducing their positions, and 7 closing their positions.
Holders
34
Holders Change
+9
Holders Change %
+36%
% of All Funds
0.78%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
9
Reduced
4
Closed
7
Calls
$21K
Puts
$3K
Net Calls
+$18K
Net Calls Change
+$227K
Top Buyers
1 |
1
BlackRock
New York
|
$11.5M |
2 |
2
State Street
Boston,
Massachusetts
|
$2.77M |
3 |
3
Northern Trust
Chicago,
Illinois
|
$1.6M |
4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$3.45M |
5 |
5
Geode Capital Management
Boston,
Massachusetts
|
$1.8M |